Cardiac positron emission tomography (PET) uses radionuclide tracers to evaluate heart tissue functioning. It is especially useful for detecting the type of heart disease that reduces blood flow to the heart muscle. It is specific enough to identify injured, yet living heart muscle.
82 Cardiac Perfusion Imaging is known and recognized as a powerful tool in the assessment of coronary artery disease (CAD). The high sensitivity, specificity and accuracy of cardiac perfusion imaging can potentially reduce the costs associated with CAD by decreasing the need for more expensive and higher risk, invasive procedures. CardioGen-82 is the only FDA approved generator-based perfusion agent reimbursed for the evaluation of CAD.